Skip to content

Microbiota

Cobra provides scale up and manufacturing of customers’ live biotherapeutic microbiota products, manufacturing to cGMP standards for pre-clinical, clinical and commercial scale. Cobra is proud to be a part of the ELIMOX consortium; inspiring hope through medical advances.

Microbiota

Hosts

  • Listeria monocytogenes (recombinant, attenuated)
  • Oxalobacter formigenes (wild type, anaerobic)
  • Salmonella tyhpi (recombinant, attenuated)
  • Salmonella typhimurium (recombinant, attenuated)
  • Serratia marcescens (wild type, heat-killed at end of process)
  • Streptococcus pyogenes (wild type, heat-killed at end of process)

Analytical Development & Qualification

  • Analytical method transfer, development, qualification & validation
  • Analytical methods include: Identity by microbiological characterisation of the strain, purity (monosepsis), strength by determination of viability, development of cell based potency assays

GMP Manufacturing

Cobra provides expert contract manufacturing of whole cell microbiota vaccines in compliance with cGMP standards.

  • Master Cell Bank & Working Cell Bank production
  • Pre-clinical and clinical supply
  • Aerobic and anaerobic cell capability

Get In Touch

Speak to a member of our expert team and arrange to take a tour of our GMP facilities in the UK and Sweden

This website uses cookies. For more information about these please click here.
By continuing to browse you consent to the use of cookies